Rohto Pharmaceutical Co (4527N) Revenue

0 Followers

Rohto Pharmaceutical Co Revenue

Rohto Pharmaceutical Co had a revenue of 82.29B in the quarter ending Sep 30, 2026, with 0.40%. This bring the company's revenue in the last twelve months to 333.80B, Decreased 3.59%. In the fiscal year ending Mar 31, 2026, Rohto Pharmaceutical Co had annual revenue of 308.63B with -10.21% growth.

Revenue (ttm)

333.80B

Revenue Growth

-3.45%

P/S Ratio

0.24

Revenue/Employee

$33,214,055

Employees

9,292

Market Cap

$75.09B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	308.63B	-35.10B	-10.21%
Mar 31, 2026	343.73B	72.89B	+26.91%
Mar 31, 2025	270.84B	32.18B	+13.48%
Mar 31, 2024	238.66B	39.02B	+19.54%
Mar 31, 2023	199.65B	18.59B	+10.27%
Mar 31, 2022	181.05B	-7.32B	-3.89%
Mar 31, 2021	188.38B	4.70B	+2.56%
Mar 31, 2020	183.67B	11.88B	+6.91%
Mar 31, 2019	171.79B	17.20B	+11.12%
Mar 31, 2017	154.60B	―	―